Mystic Pharmaceuticals Appoints Gerald D. Cagle Ph.D. And Grady Rylander M.D. To Scientific Advisory Board

Mystic Pharmaceuticals, Inc., a privately held integrated specialty pharmaceutical company, announced today that Gerald D. Cagle Ph.D. and Grady Rylander M.D. have joined Mystic's Scientific Advisory Board. Dr. Cagle is the former Chief Scientific Officer and Senior Vice President of Research and Development of Alcon Laboratories, Inc. Dr. Rylander is a board certified ophthalmologist with the Eye Institute of Austin and a Professor in Biomedical Engineering at the University of Texas-Austin. 

Suggested Articles

In this week's EuroBiotech Report, AstraZeneca plans 2020 lupus filing, Roche's SMA trial hits endpoint and Kiadis cuts staff in R&D pivot.

In our EuroBiotech roundup this week, NEC and Vaximm ink cancer vaccine pact, Compugen posts cancer data and Lunac raises cash.

Biotech venture fund ATAI Life Sciences has partnered with artificial intelligence drug discovery specialist Cyclica to form a new JV.